273 related articles for article (PubMed ID: 22417086)
1. Expression of TREM-1 in hepatic stellate cells and prognostic value in hepatitis B-related hepatocellular carcinoma.
Liao R; Sun TW; Yi Y; Wu H; Li YW; Wang JX; Zhou J; Shi YH; Cheng YF; Qiu SJ; Fan J
Cancer Sci; 2012 Jun; 103(6):984-92. PubMed ID: 22417086
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance and gene expression study of human hepatic stellate cells in HBV related-hepatocellular carcinoma.
Liao R; Wu H; Yi Y; Wang JX; Cai XY; He HW; Cheng YF; Zhou J; Fan J; Sun J; Qiu SJ
J Exp Clin Cancer Res; 2013 Apr; 32(1):22. PubMed ID: 23601182
[TBL] [Abstract][Full Text] [Related]
3. TREM-2 defends the liver against hepatocellular carcinoma through multifactorial protective mechanisms.
Esparza-Baquer A; Labiano I; Sharif O; Agirre-Lizaso A; Oakley F; Rodrigues PM; Zhuravleva E; O'Rourke CJ; Hijona E; Jimenez-Agüero R; Riaño I; Landa A; La Casta A; Zaki MYW; Munoz-Garrido P; Azkargorta M; Elortza F; Vogel A; Schabbauer G; Aspichueta P; Andersen JB; Knapp S; Mann DA; Bujanda L; Banales JM; Perugorria MJ
Gut; 2021 Jul; 70(7):1345-1361. PubMed ID: 32907830
[TBL] [Abstract][Full Text] [Related]
4. TREM-1, an inflammatory modulator, is expressed in hepatocellular carcinoma cells and significantly promotes tumor progression.
Duan M; Wang ZC; Wang XY; Shi JY; Yang LX; Ding ZB; Gao Q; Zhou J; Fan J
Ann Surg Oncol; 2015 Sep; 22(9):3121-9. PubMed ID: 25465376
[TBL] [Abstract][Full Text] [Related]
5. Hepatic stellate cells activated by acidic tumor microenvironment promote the metastasis of hepatocellular carcinoma via osteopontin.
Song J; Ge Z; Yang X; Luo Q; Wang C; You H; Ge T; Deng Y; Lin H; Cui Y; Chu W; Yao M; Zhang Z; Gu J; Fan J; Qin W
Cancer Lett; 2015 Jan; 356(2 Pt B):713-20. PubMed ID: 25449435
[TBL] [Abstract][Full Text] [Related]
6. [Correlation of triggering receptors expressed on myeloid cells-1 with the oncogenesis and progression of hepatocellular carcinoma].
Li W; Zhang N; Ou Y; Zhou Z; Zhao F; Wu Q; Yang Y
Nan Fang Yi Ke Da Xue Xue Bao; 2015 Dec; 35(12):1705-9, 1720. PubMed ID: 26714901
[TBL] [Abstract][Full Text] [Related]
7. Hepatic stellate cell and monocyte interaction contributes to poor prognosis in hepatocellular carcinoma.
Ji J; Eggert T; Budhu A; Forgues M; Takai A; Dang H; Ye Q; Lee JS; Kim JH; Greten TF; Wang XW
Hepatology; 2015 Aug; 62(2):481-95. PubMed ID: 25833323
[TBL] [Abstract][Full Text] [Related]
8. High-mobility group protein box1 expression correlates with peritumoral macrophage infiltration and unfavorable prognosis in patients with hepatocellular carcinoma and cirrhosis.
Zhang QB; Jia QA; Wang H; Hu CX; Sun D; Jiang RD; Zhang ZL
BMC Cancer; 2016 Nov; 16(1):880. PubMed ID: 27836008
[TBL] [Abstract][Full Text] [Related]
9. Rat hepatic stellate cells alter the gene expression profile and promote the growth, migration and invasion of hepatocellular carcinoma cells.
Wang ZM; Zhou LY; Liu BB; Jia QA; Dong YY; Xia YH; Ye SL
Mol Med Rep; 2014 Oct; 10(4):1725-33. PubMed ID: 25109274
[TBL] [Abstract][Full Text] [Related]
10. Cluster of differentiation 147 is a key molecule during hepatocellular carcinoma cell-hepatic stellate cell cross-talk in the rat liver.
Ma T; Wang Z; Yang Z; Chen J
Mol Med Rep; 2015 Jul; 12(1):111-8. PubMed ID: 25738354
[TBL] [Abstract][Full Text] [Related]
11. An imbalance between stellate cells and γδT cells contributes to hepatocellular carcinoma aggressiveness and recurrence.
Zhou BY; Gong JH; Cai XY; Wang JX; Luo F; Jiang N; Gong JP; Du CY; Liao R
Hepatol Int; 2019 Sep; 13(5):631-640. PubMed ID: 31342250
[TBL] [Abstract][Full Text] [Related]
12. HBV upregulated triggering receptor expressed on myeloid cells-1 (TREM-1) expression on monocytes participated in disease progression through NF-Kb pathway.
Wu X; Cai B; Lu W; Fu Y; Wei B; Niu Q; Su Z; Li Y; Wang L
Clin Immunol; 2021 Feb; 223():108650. PubMed ID: 33316373
[TBL] [Abstract][Full Text] [Related]
13. Soluble TREM-1, as a new ligand for the membrane receptor Robo2, promotes hepatic stellate cells activation and liver fibrosis.
Liu T; Chen S; Xie X; Liu H; Wang Y; Qi S; Shi L; Zhou X; Zhang J; Wang S; Wang Y; Chen S; Dou S; Jiang X; Cui R; Jiang H
J Cell Mol Med; 2021 Dec; 25(24):11113-11127. PubMed ID: 34750987
[TBL] [Abstract][Full Text] [Related]
14. miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
Yen CS; Su ZR; Lee YP; Liu IT; Yen CJ
World J Gastroenterol; 2016 Jun; 22(22):5183-92. PubMed ID: 27298561
[TBL] [Abstract][Full Text] [Related]
15. Activated hepatic stellate cells promote hepatocellular carcinoma development in immunocompetent mice.
Zhao W; Zhang L; Yin Z; Su W; Ren G; Zhou C; You J; Fan J; Wang X
Int J Cancer; 2011 Dec; 129(11):2651-61. PubMed ID: 21213212
[TBL] [Abstract][Full Text] [Related]
16. Periostin involved in the activated hepatic stellate cells-induced progression of residual hepatocellular carcinoma after sublethal heat treatment: its role and potential for therapeutic inhibition.
Zhang R; Lin XH; Ma M; Chen J; Chen J; Gao DM; Cui JF; Chen RX
J Transl Med; 2018 Nov; 16(1):302. PubMed ID: 30400797
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B virus (HBV) receptors: Deficiency in tumor results in scant HBV infection and overexpression in peritumor leads to higher recurrence risk.
Jing YY; Liu WT; Guo SW; Ye F; Fan QM; Yu GF; Yu DD; Gao L; Sun K; Han ZP; Li R; Yang Y; Zhao QD; Wu MC; Wang HY; Wei LX
Oncotarget; 2015 Dec; 6(40):42952-62. PubMed ID: 26515593
[TBL] [Abstract][Full Text] [Related]
18. Icaritin-induced immunomodulatory efficacy in advanced hepatitis B virus-related hepatocellular carcinoma: Immunodynamic biomarkers and overall survival.
Qin SK; Li Q; Ming Xu J; Liang J; Cheng Y; Fan Y; Jiang J; Ye H; Tao H; Li L; Zheng L; Wei Z; Li S; Meng K; Ye B; Sun Y
Cancer Sci; 2020 Nov; 111(11):4218-4231. PubMed ID: 32889778
[TBL] [Abstract][Full Text] [Related]
19. Hepatic stellate cells stimulate HCC cell migration via laminin-5 production.
Santamato A; Fransvea E; Dituri F; Caligiuri A; Quaranta M; Niimi T; Pinzani M; Antonaci S; Giannelli G
Clin Sci (Lond); 2011 Aug; 121(4):159-68. PubMed ID: 21413933
[TBL] [Abstract][Full Text] [Related]
20. ERK pathway activation contributes to the tumor-promoting effects of hepatic stellate cells in hepatocellular carcinoma.
Xie YX; Liao R; Pan L; Du CY
Immunol Lett; 2017 Aug; 188():116-123. PubMed ID: 28668554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
